WAY-100635 is a potent dopamine D4 receptor agonist

被引：0
|
作者：
Benjamin R. Chemel
Bryan L. Roth
Blaine Armbruster
Val J. Watts
David E. Nichols
机构：
[1] Purdue University,Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences
[2] Psychiatry,Departments of Biochemistry
[3] Neurosciences and NIMH Psychoactive Drug Screening Program,undefined
[4] Case Western Reserve University Medical School,undefined
来源：
Psychopharmacology | 2006年 / 188卷
关键词：
WAY-100635; WAY-100634; 5-HT; D; D; Receptor selectivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：244 / 251
页数：7
相关论文
共 50 条
  • [41] ADTN - A POTENT DOPAMINE RECEPTOR AGONIST
    WOODRUFF, GN
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (02) : 59 - 61
  • [42] Facilitation of penile erection by ABT-724, a novel and selecitve dopamine D4 receptor agonist
    Brioni, JD
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S14 - S14
  • [43] Behavioural effects of APH199, a selective dopamine D4 receptor agonist, in animal models
    Chestnykh, Daria
    Grassl, Fabian
    Pfeifer, Canice
    Duelk, Jonas
    Ebner, Chiara
    Walters, Mona
    von Hoersten, Stephan
    Kornhuber, Johannes
    Kalinichenko, Liubov S. S.
    Heinrich, Markus
    Mueller, Christian P.
    PSYCHOPHARMACOLOGY, 2023, 240 (04) : 1011 - 1031
  • [44] Behavioural effects of APH199, a selective dopamine D4 receptor agonist, in animal models
    Daria Chestnykh
    Fabian Graßl
    Canice Pfeifer
    Jonas Dülk
    Chiara Ebner
    Mona Walters
    Stephan von Hörsten
    Johannes Kornhuber
    Liubov S. Kalinichenko
    Markus Heinrich
    Christian P. Müller
    Psychopharmacology, 2023, 240 : 1011 - 1031
  • [45] New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma
    Matteucci, Federica
    Pavletic, Pegi
    Bonifazi, Alessandro
    Del Bello, Fabio
    Giorgioni, Gianfabio
    Piergentili, Alessandro
    Amantini, Consuelo
    Zeppa, Laura
    Sabato, Emanuela
    Vistoli, Giulio
    Garland, Rian
    Yano, Hideaki
    Castagna, Monica
    Mammoli, Valerio
    Cappellacci, Loredana
    Piergentili, Alessia
    Quaglia, Wilma
    JOURNAL OF MEDICINAL CHEMISTRY, 2025,
  • [46] Synthesis of potent and selective dopamine D4 antagonists as candidate radioligands
    Huang, YY
    Kegeles, LS
    Bae, SA
    Hwang, DR
    Roth, BL
    Savage, JE
    Laruelle, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1375 - 1377
  • [47] Conformational analysis of tandospirone in aqueous solution:: Lead evolution of potent dopamine D4 receptor ligands
    Nishimura, T
    Igarashi, J
    Sunagawa, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) : 1141 - 1144
  • [48] Discovery of potent dual ligands for dopamine D4 and σ1 receptors
    Levoin, Nicolas
    Murthy, Appala Venkata Ramana
    Narendar, Vennu
    Kumar, Nangunoori Sampath
    Aparna, Pasula
    Bhavani, Anagani Kanaka Durga
    Reddy, Chada Raji
    Mosset, Paul
    Gree, Rene
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 69
  • [49] In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist
    Prajapati, Ritu
    Seong, Su Hui
    Paudel, Pradeep
    Park, Se Eun
    Jung, Hyun Ah
    Choi, Jae Sue
    ACS OMEGA, 2021, 6 (49): : 33443 - 33453
  • [50] The 5-HT1A receptor antagonist WAY-100635 decreases motor/exploratory behaviors and nigrostriatal and mesolimbocortical dopamine D2/3 receptor binding in adult rats
    Nikolaus, Susanne
    Wittsack, Hans-Jorg
    Beu, Markus
    Hautzel, Hubertus
    Antke, Christina
    Mamlins, Eduards
    Cardinale, Jens
    Decheva, Cvetana
    Huston, Joseph P.
    Antoch, Gerald
    Giesel, Frederik L.
    Mueller, Hans-Wilhelm
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2022, 215
12345